{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:32:55Z","timestamp":1787020375449,"version":"build-2736575974"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T00:00:00Z","timestamp":1644969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Urol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Urethrocutaneous fistula (subsequently,\n                      <jats:italic>fistula<\/jats:italic>\n                      ) is a rare adverse event (AE) in voluntary medical male circumcision (VMMC) programs. Global fistula rates of 0.19 and 0.28 per 100,000 VMMCs were reported. Management of fistula can be complex and requires expert skills. We describe seven cases of fistula in our large-scale VMMC program in Zimbabwe. We present fistula rates; provide an overview of initial management, surgical interventions, and patient outcomes; discuss causes; and suggest future prevention efforts.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Case details are presented on fistulas identified between March 2013 and October 2019. Among the seven fistula clients, ages ranged from 10 to 22\u00a0years; 6 cases were among boys under 15\u00a0years of age. All clients received surgical VMMC by trained providers in an outreach setting. Clients presented with fistulae 2\u201342\u00a0days after VMMC. Secondary infection was identified in 6 of 7 cases. Six cases were managed through surgical repair. The number of repair attempts ranged from 1 to 10. One case healed spontaneously with conservative management. Fistula rates are presented as cases\/100,000 VMMCs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Fistula is an uncommon but severe AE that requires clinical expertise for successful management and repair. High-quality AE surveillance should identify fistula promptly and include consultation with experienced urologists. Strengthening provider surgical skills and establishment of standard protocols for fistula management would aid future prevention efforts in VMMC programs.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12894-022-00973-1","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:03:57Z","timestamp":1644973437000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Urethrocutaneous fistula following VMMC: a case series from March 2013 to October 2019 in ZAZIC\u2019s voluntary medical male circumcision program in Zimbabwe"],"prefix":"10.1186","volume":"22","author":[{"given":"Vernon","family":"Murenje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Omollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paidemoyo","family":"Gonouya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinashe","family":"Munyaradzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phiona","family":"Marongwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mufuta","family":"Tshimanga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vuyelwa","family":"Chitimbire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinokuthemba","family":"Xaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Mandisarisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirish","family":"Balachandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batsirai","family":"Makunike-Chikwinya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marrianne","family":"Holec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonderayi","family":"Mangwiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Barnhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caryl","family":"Feldacker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,16]]},"reference":[{"issue":"03","key":"973_CR1","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1097\/QAI.0b013e31825cac4e","volume":"60 Suppl 3","author":"JB Reed","year":"2012","unstructured":"Reed JB, Njeuhmeli E, Thomas AG, Bacon MC, Bailey R, Cherutich P, et al. Voluntary medical male circumcision: an HIV prevention priority for PEPFAR. J Acquir Immune Defic Syndr. 2012;60 Suppl 3(03):S88\u201395.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"11","key":"973_CR2","doi-asserted-by":"publisher","first-page":"337","DOI":"10.15585\/mmwr.mm6711a6","volume":"67","author":"LE Hinkle","year":"2018","unstructured":"Hinkle LE, Toledo C, Grund JM, Byams VR, Bock N, Ridzon R, et al. Bleeding and blood disorders in clients of voluntary medical male circumcision for HIV prevention\u2014eastern and southern Africa, 2015\u20132016. MMWR Morb Mortal Wkly Rep. 2018;67(11):337\u20139.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"973_CR3","unstructured":"World Health Organization. Voluntary medical male circumcision: remarkable progress in the scale up of VMMC as an HIV prevention intervention in 15 ESA countries. In: Voluntary medical male circumcision: remarkable progress in the scale up of VMMC as an HIV prevention intervention in 15 ESA countries. 2019."},{"issue":"1","key":"973_CR4","doi-asserted-by":"publisher","first-page":"21394","DOI":"10.7448\/IAS.20.1.21394","volume":"20","author":"AF Bochner","year":"2017","unstructured":"Bochner AF, Feldacker C, Makunike B, Holec M, Murenje V, Stepaniak A, et al. Adverse event profile of a mature voluntary medical male circumcision programme performing PrePex and surgical procedures in Zimbabwe. J Int AIDS Soc. 2017;20(1):21394.","journal-title":"J Int AIDS Soc"},{"issue":"9","key":"973_CR5","doi-asserted-by":"publisher","first-page":"e0203292","DOI":"10.1371\/journal.pone.0203292","volume":"13","author":"C Feldacker","year":"2018","unstructured":"Feldacker C, Bochner AF, Murenje V, Makunike-Chikwinya B, Holec M, Xaba S, et al. Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe. PLoS ONE. 2018;13(9):e0203292.","journal-title":"PLoS ONE"},{"issue":"1","key":"973_CR6","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1186\/s12913-019-4604-1","volume":"19","author":"A Brito","year":"2019","unstructured":"Brito A, Korn A, Monteiro L, Mudender F, Maiela A, Come J, et al. Need for improved detection of voluntary medical male circumcision adverse events in Mozambique: a mixed-methods assessment. BMC Health Serv Res. 2019;19(1):855. https:\/\/doi.org\/10.1186\/s12913-019-4604-1.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"973_CR7","doi-asserted-by":"publisher","first-page":"19275","DOI":"10.7448\/IAS.17.1.19275","volume":"17","author":"R Phili","year":"2014","unstructured":"Phili R, Abdool-Karim Q, Ngesa O. Low adverse event rates following voluntary medical male circumcision in a high HIV disease burden public sector prevention programme in South Africa. J Int AIDS Soc. 2014;17(1):19275.","journal-title":"J Int AIDS Soc"},{"issue":"10","key":"973_CR8","doi-asserted-by":"publisher","first-page":"773","DOI":"10.2471\/BLT.12.106112","volume":"90","author":"A Herman-Roloff","year":"2012","unstructured":"Herman-Roloff A, Bailey RC, Agot K. Factors associated with the safety of voluntary medical male circumcision in Nyanza province. Kenya Bull World Health Organ. 2012;90(10):773\u201381.","journal-title":"Kenya Bull World Health Organ"},{"issue":"1","key":"973_CR9","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1097\/QAI.0000000000000535","volume":"69","author":"JB Reed","year":"2015","unstructured":"Reed JB, Grund J, Liu Y, Mwandi Z, Howard AA, McNairy ML, et al. Implementation and operational research: evaluation of loss-to-follow-up and postoperative adverse events in a voluntary medical male circumcision program in Nyanza Province, Kenya. JAIDS J Acquir Immune Defic Syndr. 2015;69(1):e13\u201323.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"7","key":"973_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jia2.25369","volume":"22","author":"A Hellar","year":"2019","unstructured":"Hellar A, Plotkin M, Lija G, Mwanamsangu A, Mkungume S, Christensen A, et al. Adverse events in a large-scale VMMC programme in Tanzania: findings from a case series analysis. J Int AIDS Soc. 2019;22(7):1\u20136.","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"973_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s12913-016-1305-x","volume":"16","author":"PK Kohler","year":"2016","unstructured":"Kohler PK, Namate D, Barnhart S, Chimbwandira F, Tippet-Barr BA, Perdue T, et al. Classification and rates of adverse events in a Malawi male circumcision program: impact of quality improvement training. BMC Health Serv Res. 2016;16(1):61. https:\/\/doi.org\/10.1186\/s12913-016-1305-x.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"973_CR12","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1186\/1471-2458-14-858","volume":"14","author":"TA Ashengo","year":"2014","unstructured":"Ashengo TA, Grund J, Mhlanga M, Hlophe T, Mirira M, Bock N, et al. Feasibility and validity of telephone triage for adverse events during a voluntary medical male circumcision campaign in Swaziland. BMC Public Health. 2014;14(1):858. https:\/\/doi.org\/10.1186\/1471-2458-14-858.","journal-title":"BMC Public Health"},{"issue":"1","key":"973_CR13","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12894-020-00613-6","volume":"20","author":"TJ Lucas","year":"2020","unstructured":"Lucas TJ, Toledo C, Davis SM, Watts DH, Cavanaugh JS, Kiggundu V, et al. Case series of glans injuries during voluntary medical male circumcision for HIV prevention\u2014eastern and southern Africa, 2015\u20132018. BMC Urol. 2020;20(1):45. https:\/\/doi.org\/10.1186\/s12894-020-00613-6.","journal-title":"BMC Urol"},{"issue":"1","key":"973_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/s12894-019-0462-8","volume":"19","author":"M Manentsa","year":"2019","unstructured":"Manentsa M, Mukudu H, Koloane N, Ringane A, Matta E, Martinson NA, et al. Complications of high volume circumcision: glans amputation in adolescents; a case report. BMC Urol. 2019;19(1):65. https:\/\/doi.org\/10.1186\/s12894-019-0462-8.","journal-title":"BMC Urol"},{"key":"973_CR15","unstructured":"WHO. Improving surgical male circumcision practice through experience: preventing urethral fistula. Ensuring the safety of patients during male circumcision for HIV prevention by learning from rare adverse events. Male Circumcision For HIV Prevention Urethral Fistula. 2019."},{"key":"973_CR16","unstructured":"UNAIDS WH. UNAIDS and WHO Progress Brief: voluntary medical male circumcision, November 2019. 2019 [cited 2020 Aug 30]. www.who.int\/hiv."},{"issue":"1","key":"973_CR17","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12894-021-00790-y","volume":"21","author":"T Lucas","year":"2021","unstructured":"Lucas T, Hines JZ, Samuelson J, Hargreave T, Davis SM, Fellows I, et al. Urethrocutaneous fistulas after voluntary medical male circumcision for HIV prevention-15 African Countries, 2015\u20132019. BMC Urol. 2021;21(1):23.","journal-title":"BMC Urol"},{"issue":"3","key":"973_CR18","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1046\/j.1464-410x.2000.00101.x","volume":"86","author":"CR Chapple","year":"2000","unstructured":"Chapple CR. Urethral injury. BJU Int. 2000;86(3):318\u201326. https:\/\/doi.org\/10.1046\/j.1464-410x.2000.00101.x.","journal-title":"BJU Int"},{"key":"973_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/375285","author":"JH Kim","year":"2014","unstructured":"Kim JH, Park JY, Song YS. Traumatic penile injury: from circumcision injury to penile amputation. Biomed Res Int. 2014. https:\/\/doi.org\/10.1155\/2014\/375285.","journal-title":"Biomed Res Int"},{"key":"973_CR20","unstructured":"Coordinator O of the USGA. Alternative surgical methods for adolescent voluntary medical male circumcision (VMMC) Clients. 2014."},{"key":"973_CR21","unstructured":"WHO. Tetanus and voluntary medical male circumcision: risk according to circumcision method and risk mitigation Report of the WHO Technical Advisory Group on Innovations in Male Circumcision-consultative review of additional information. 2016 [cited 2020 Aug 30]. http:\/\/www.who.int."},{"key":"973_CR22","unstructured":"Murenje V. ZAZIC urethrocutaneous fistula cases. In: Presented at: Project IQ Webinar: Emerging safety issues in VMMC. Harare, Zimbabwe: Jhpiego Corporation; 2017."},{"key":"973_CR23","doi-asserted-by":"crossref","unstructured":"Pierre DE. Mouriquand, Delphine Dem\u00e8de, Daniela Gorduza P-YM. Hypospadias. In: Pediatric urology, 2nd ed. 2010. p. 526\u201343.","DOI":"10.1016\/B978-1-4160-3204-5.00041-4"},{"issue":"2","key":"973_CR24","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0022-5347(05)64734-9","volume":"168","author":"BJ Waterman","year":"2002","unstructured":"Waterman BJ, Renschler T, Cartwright PC, Snow BW, DeVries CR. Variables in successful repair of urethrocutaneous fistula after hypospadias surgery. J Urol. 2002;168(2):726\u201330.","journal-title":"J Urol"},{"issue":"4","key":"973_CR25","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1097\/00000637-200044040-00005","volume":"44","author":"O Latifo\u011flu","year":"2000","unstructured":"Latifo\u011flu O, Yavuzer R, Unal S, Cavu\u015fo\u011flu T, Atabay K. Surgical treatment of urethral fistulas following hypospadias repair. Ann Plast Surg. 2000;44(4):381\u20136.","journal-title":"Ann Plast Surg"},{"key":"973_CR26","unstructured":"WHO. Preventing hiv through safe voluntary medical male circumcision for adolescent boys and men in generalized epidemics: recommendations and key considerations. 2020. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/333841\/9789240009660-eng.pdf."},{"key":"973_CR27","unstructured":"Hargreave, Timothy, Galukande M. No title. In: WHO consultation on management of urethral fistula adverse events following medical male circumcision for HIV prevention. Harare, Zimbabwe."},{"key":"973_CR28","unstructured":"PEPFAR. PEPFAR 2020 country operational plan guidance for all PEPFAR countries. 2020. https:\/\/www.state.gov\/wp-content\/uploads\/2020\/01\/COP20-Guidance.pdf."},{"issue":"9","key":"973_CR29","doi-asserted-by":"publisher","first-page":"e0203292","DOI":"10.1371\/journal.pone.0203292PMID","volume":"13","author":"C Feldacker","year":"2018","unstructured":"Feldacker C, Bochner AF, Murenje V, Makunike-Chikwinya B, Holec M, Xaba S, et al. Correction: Timing of adverse events among voluntary medical male circumcision clients: Implications from routine service delivery in Zimbabwe. PLoS ONE. 2018;13(9):e0203292. https:\/\/doi.org\/10.1371\/journal.pone.0203292PMID.","journal-title":"PLoS ONE"},{"issue":"suppl_3","key":"973_CR30","doi-asserted-by":"publisher","first-page":"S229","DOI":"10.1093\/cid\/cix953","volume":"66","author":"W Mavhu","year":"2018","unstructured":"Mavhu W, Hatzold K, Dam KH, Kaufman MR, Patel EU, Van Lith LM, et al. Adolescent wound-care self-efficacy and practices after voluntary medical male circumcision-a multicountry assessment. Clin Infect Dis. 2018;66(suppl_3):S229\u201335.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"973_CR31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/j.1464-410X.2009.08420.x","volume":"104","author":"V Kiggundu","year":"2009","unstructured":"Kiggundu V, Watya S, Kigozi G, Serwadda D, Nalugoda F, Buwembo D, et al. The number of procedures required to achieve optimal competency with male circumcision: findings from a randomized trial in Rakai. Uganda BJU Int. 2009;104(4):529\u201332.","journal-title":"Uganda BJU Int"},{"issue":"3","key":"973_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1159\/000099344","volume":"78","author":"JN Krieger","year":"2007","unstructured":"Krieger JN, Bailey RC, Opeya JC, Ayieko BO, Opiyo FA, Omondi D, et al. Adult male circumcision outcomes: experience in a developing country setting. Urol Int. 2007;78(3):235\u201340.","journal-title":"Urol Int"},{"issue":"1","key":"973_CR33","doi-asserted-by":"publisher","first-page":"93","DOI":"10.9745\/GHSP-D-13-00120","volume":"2","author":"V Frajzyngier","year":"2014","unstructured":"Frajzyngier V, Odingo G, Barone M, Perchal P, Pavin M. Safety of adult medical male circumcision performed by non-physician clinicians in Kenya: a prospective cohort study. Glob Heal Sci Pract. 2014;2(1):93\u2013102.","journal-title":"Glob Heal Sci Pract"},{"issue":"6","key":"973_CR34","doi-asserted-by":"publisher","first-page":"e0218137","DOI":"10.1371\/journal.pone.0218137","volume":"14","author":"P Marongwe","year":"2019","unstructured":"Marongwe P, Gonouya P, Madoda T, Murenje V, Tshimanga M, Balachandra S, et al. Trust but verify: is there a role for active surveillance in monitoring adverse events in Zimbabwe\u2019s large-scale male circumcision program? PLoS ONE. 2019;14(6):e0218137. https:\/\/doi.org\/10.1371\/journal.pone.0218137.","journal-title":"PLoS ONE"}],"container-title":["BMC Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-022-00973-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12894-022-00973-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12894-022-00973-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T01:07:26Z","timestamp":1644973646000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcurol.biomedcentral.com\/articles\/10.1186\/s12894-022-00973-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["973"],"URL":"https:\/\/doi.org\/10.1186\/s12894-022-00973-1","relation":{},"ISSN":["1471-2490"],"issn-type":[{"value":"1471-2490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,16]]},"assertion":[{"value":"31 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 February 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval for this routine program monitoring and evaluation using de-identified data were provided by Medical Research Council of Zimbabwe (MRCZ) and the US Centers for Disease Control and Prevention (CDC) Center for Global Health. Specific language in the approval includes quality assurance activities focused on fistulas and other severe, rare adverse events. This care series does not meet the criteria for <i>research<\/i> according to U.S. Federal Office for Human Research Protections; therefore, this specific activity was not reviewed by the University of Washington Internal Review Board.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication of de-identified data was waived by Medical Research Council of Zimbabwe\u2019s (MRCZ) National Health Research Development Committee and the US Centers for Disease Control and Prevention (CDC) Center for Global Health\u2019s Office of Associate Director for Science.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declares that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}